There was no statistically significant association observed between OS and the presence of FoxP3+ Tregs in patients diagnosed with cholangiocarcinoma (HR = 1.00, 95% CI 0.62 to 1.38; P > .05). This evidence concerns the gene FOXP3 and cholangiocarcinoma.